Haemonetics (HAE): Officer had shares withheld for tax 313 shares
Laurie A. Miller, Officer at Haemonetics, reported a tax withholding of 313 shares.
- 313
- Shares · @ $71.28
- Traded
- Jun 5, 2026
- Filed
- Jun 8, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 4, 2025Federal contract · $6K obligatedDepartment of Defense awarded HAEMONETICS CORP: $6.1K obligated to date
- Feb 12, 2026Federal contract · $88K obligatedDepartment of Defense awarded HAEMONETICS CORP: $88K obligated to date
- Mar 10, 2026Federal contract · $50K obligatedDepartment of Veterans Affairs awarded HAEMONETICS CORP: $50K obligated to date
- Apr 16, 2026Federal contract · $132K obligatedNational Aeronautics and Space Administration awarded HAEMONETICS CORP: $132K obligated to date
- Apr 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 27, 2026, Charles J. Dockendorff informed Haemonetics Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”).”
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 12, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded HAEMONETICS CORP: $23K obligated to date
- May 19, 2026Federal contract · $84K obligatedDepartment of Defense awarded HAEMONETICS CORP: $84K obligated to date
What came next
- Jul 24, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On July 24, 2026, the Board of Directors of Haemonetics Corporation (the “Company”) elected Martin Madaus as a director of the Company, effective immediately. Dr. Madaus currently serves as Senior Operating Executive at The Carlyle Group, where since 2019 he has advised on healthcare investments and portfolio company performance.”
- Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 14, 2026Federal contract · $27K obligatedDepartment of Veterans Affairs awarded HAEMONETICS CORP: $27K obligated to date
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Haemonetics
For Haemonetics, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HAE page.
How this filing works
Explore the data
Common questions
Which Haemonetics (HAE) insider traded, and how much?
Laurie A. Miller, Officer at Haemonetics, reported a tax withholding of 313 shares. At $71.28.
When did it happen, and when was it made public?
Traded: Jun 5, 2026. Filed: Jun 8, 2026. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Haemonetics recently?
For Haemonetics, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the HAE page.
Does this mean HAE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Haemonetics
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 144Nov 12, 2026
- USAspending.gov award recordSep 23, 2026
- USAspending.gov award recordSep 21, 2026
- USAspending.gov award recordSep 21, 2026
Everything OQRO holds on this company is on its HAE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
